{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:50:07Z","timestamp":1784191807538,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T00:00:00Z","timestamp":1323129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00520-011-1333-3","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T02:09:06Z","timestamp":1323050946000},"page":"2295-2304","source":"Crossref","is-referenced-by-count":18,"title":["A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia"],"prefix":"10.1007","volume":"20","author":[{"given":"Arif","family":"Manji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Lee","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"key":"1333_CR1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/pbc.21179","volume":"49","author":"N Ahmed","year":"2007","unstructured":"Ahmed N, El-Mahallawy HA, Ahmed IA, Nassif S, El-Beshlawy A, El-Haddad A (2007) Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: a randomized, prospective study. Pediatr Blood Cancer 49:786\u2013792","journal-title":"Pediatr Blood Cancer"},{"key":"1333_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/08880010490277321","volume":"21","author":"S Aksoylar","year":"2004","unstructured":"Aksoylar S, Cetingul N, Kantar M, Karapinar D, Kavakli K, Kansoy S (2004) Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. Pediatr Hematol Oncol 21:115\u2013123","journal-title":"Pediatr Hematol Oncol"},{"key":"1333_CR3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00431-004-1461-6","volume":"163","author":"C Berger","year":"2004","unstructured":"Berger C, Kindli K, Niggli FK, Nadal D (2004) Withholding initial vancomycin in febrile neutropenia despite implanted catheters. Eur J Pediatr 163:422\u2013423","journal-title":"Eur J Pediatr"},{"key":"1333_CR4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"GP Bodey","year":"1966","unstructured":"Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328\u2013340","journal-title":"Ann Intern Med"},{"key":"1333_CR5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/27.5.669","volume":"27","author":"PH Bolton-Maggs","year":"1991","unstructured":"Bolton-Maggs PH, van Saene HK, McDowell HP, Martin J (1991) Clinical evaluation of ticarcillin, with clavulanic acid, and gentamicin in the treatment of febrile episodes in neutropenic children. J Antimicrob Chemother 27:669\u2013676","journal-title":"J Antimicrob Chemother"},{"key":"1333_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08880010500506370","volume":"23","author":"F Corapcioglu","year":"2006","unstructured":"Corapcioglu F, Sarper N, Zengin E (2006) Monotherapy with piperacillin\/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison. Pediatr Hematol Oncol 23:177\u2013186","journal-title":"Pediatr Hematol Oncol"},{"key":"1333_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"1333_CR8","first-page":"105","volume":"43","author":"A Duzova","year":"2001","unstructured":"Duzova A, Kutluk T, Kanra G et al (2001) Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors. Turk J Pediatr 43:105\u2013109","journal-title":"Turk J Pediatr"},{"issue":"10","key":"1333_CR9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/0011-393X(95)85117-8","volume":"56","author":"AMA El Haddad","year":"1995","unstructured":"El Haddad AMA (1995) Comparison of cefoperazone\u2013sulbactam versus piperacillin plus amikacin as empiric therapy in pediatric febrile neutropenic cancer patients. Curr Ther Res Clin Exp 56(10):1094\u20131099","journal-title":"Curr Ther Res Clin Exp"},{"key":"1333_CR10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jac\/47.6.841","volume":"47","author":"G Fleischhack","year":"2001","unstructured":"Fleischhack G, Hartmann C, Simon A et al (2001) Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chemother 47:841\u2013853","journal-title":"J Antimicrob Chemother"},{"key":"1333_CR11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s005200000225","volume":"9","author":"G Fleischhack","year":"2001","unstructured":"Fleischhack G, Schmidt-Niemann M, Wulff B et al (2001) Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients. Support Care Cancer 9:372\u2013379","journal-title":"Support Care Cancer"},{"key":"1333_CR12","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56\u2013e93","journal-title":"Clin Infect Dis"},{"key":"1333_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1473-3099(02)00241-4","volume":"2","author":"P Furno","year":"2002","unstructured":"Furno P, Bucaneve G, Del Favero A (2002) Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. Lancet Infect Dis 2:231\u2013242","journal-title":"Lancet Infect Dis"},{"key":"1333_CR14","first-page":"13","volume":"6","author":"M Gonzalez","year":"1987","unstructured":"Gonzalez M, Clavell LA (1987) Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia. P R Health Sci J 6:13\u201315","journal-title":"P R Health Sci J"},{"key":"1333_CR15","first-page":"26","volume":"49","author":"A Hamidah","year":"2008","unstructured":"Hamidah A, Rizal AM, Nordiah AJ, Jamal R (2008) Piperacillin\u2013tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients. Singapore Med J 49:26\u201330","journal-title":"Singapore Med J"},{"key":"1333_CR16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","volume":"144","author":"JA Hayden","year":"2006","unstructured":"Hayden JA, Cote P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144:427\u2013437","journal-title":"Ann Intern Med"},{"key":"1333_CR17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1651-2227.2005.tb03068.x","volume":"94","author":"S Hemsworth","year":"2005","unstructured":"Hemsworth S, Nunn AJ, Selwood K, Osborne C, Jones A, Pizer B (2005) Once-daily netilmicin for neutropenic pyrexia in paediatric oncology. Acta Paediatr 94:268\u2013274","journal-title":"Acta Paediatr"},{"key":"1333_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/28.1.117","volume":"28","author":"D Heney","year":"1991","unstructured":"Heney D, Lewis IJ, Ghoneim AT, Chisholm P, Bailey CC (1991) Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin. J Antimicrob Chemother 28:117\u2013129","journal-title":"J Antimicrob Chemother"},{"key":"1333_CR19","first-page":"254","volume":"36","author":"KC Hung","year":"2003","unstructured":"Hung KC, Chiu HH, Tseng YC et al (2003) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy. J Microbiol Immunol Infect 36:254\u2013259","journal-title":"J Microbiol Immunol Infect"},{"key":"1333_CR20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/655131","volume":"51","author":"PW Kim","year":"2010","unstructured":"Kim PW, Wu YT, Cooper C et al (2010) Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis 51:381\u2013389","journal-title":"Clin Infect Dis"},{"key":"1333_CR21","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky J, Paesmans M, Rubenstein EB et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038\u20133051","journal-title":"J Clin Oncol"},{"key":"1333_CR22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/pbc.10442","volume":"42","author":"T Kutluk","year":"2004","unstructured":"Kutluk T, Kurne O, Akyuz C et al (2004) Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours. Pediatr Blood Cancer 42:284\u2013286","journal-title":"Pediatr Blood Cancer"},{"key":"1333_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"1333_CR24","first-page":"331","volume":"29","author":"MG Miranda-Novales","year":"1998","unstructured":"Miranda-Novales MG, Belmont-Martinez L, Villasis-Keever MA, Penagos-Paniagua M, Bernaldez-Rios R, Solorzano-Santos F (1998) Empirical antimicrobial therapy in pediatric patients with neutropenia and fever. Risk factors for treatment failure. Arch Med Res 29:331\u2013335","journal-title":"Arch Med Res"},{"issue":"Suppl A","key":"1333_CR25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jac\/12.suppl_A.347","volume":"12","author":"G Morgan","year":"1983","unstructured":"Morgan G, Duerden BI, Lilleyman JS (1983) Ceftazidime as a single agent in the management of children with fever and neutropenia. J Antimicrob Chemother 12(Suppl A):347\u2013351","journal-title":"J Antimicrob Chemother"},{"key":"1333_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/08880010500506867","volume":"23","author":"A Oguz","year":"2006","unstructured":"Oguz A, Karadeniz C, Citak EC, Cil V, Eldes N (2006) Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors. Pediatr Hematol Oncol 23:245\u2013253","journal-title":"Pediatr Hematol Oncol"},{"issue":"Suppl 2","key":"1333_CR27","first-page":"S174","volume":"86","author":"C Pancharoen","year":"2003","unstructured":"Pancharoen C, Mekmullica J, Buranachonapa J et al (2003) Efficacy and safety of meropenem as an empirical treatment for febrile neutropenia in children with cancer. J Med Assoc Thai 86(Suppl 2):S174\u2013S178","journal-title":"J Med Assoc Thai"},{"key":"1333_CR28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.326.7399.1111","volume":"326","author":"M Paul","year":"2003","unstructured":"Paul M, Soares-Weiser K, Leibovici L (2003) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 326:1111","journal-title":"BMJ"},{"key":"1333_CR29","doi-asserted-by":"crossref","unstructured":"Paul M, Yahav D, Bivas A, Fraser A, Leibovici L (2010) Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. Cochrane Database Syst Rev: CD005197","DOI":"10.1002\/14651858.CD005197.pub3"},{"key":"1333_CR30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S1413-86702003000200003","volume":"7","author":"AS Petrilli","year":"2003","unstructured":"Petrilli AS, Cypriano M, Dantas LS et al (2003) Evaluation of ticarcillin\/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma. Braz J Infect Dis 7:111\u2013120","journal-title":"Braz J Infect Dis"},{"key":"1333_CR31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","volume":"328","author":"PA Pizzo","year":"1993","unstructured":"Pizzo PA (1993) Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328:1323\u20131332","journal-title":"N Engl J Med"},{"key":"1333_CR32","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00006454-199112000-00008","volume":"10","author":"P Riikonen","year":"1991","unstructured":"Riikonen P (1991) Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. Pediatr Infect Dis J 10:918\u2013923","journal-title":"Pediatr Infect Dis J"},{"key":"1333_CR33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","volume":"284","author":"S Schimpff","year":"1971","unstructured":"Schimpff S, Satterlee W, Young VM, Serpick A (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284:1061\u20131065","journal-title":"N Engl J Med"},{"key":"1333_CR34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1056\/NEJM198810203191604","volume":"319","author":"JL Shenep","year":"1988","unstructured":"Shenep JL, Hughes WT, Roberson PK et al (1988) Vancomycin, ticarcillin, and amikacin compared with ticarcillin\u2013clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med 319:1053\u20131058","journal-title":"N Engl J Med"},{"key":"1333_CR35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0163-4453(90)91019-A","volume":"20","author":"L Smith","year":"1990","unstructured":"Smith L, Will AM, Williams RF, Stevens RF (1990) Ceftriaxone vs. azlocillin and netilmicin in the treatment of febrile neutropenic children. J Infect 20:201\u2013206","journal-title":"J Infect"},{"key":"1333_CR36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ejca.2011.01.021","volume":"47","author":"L Sung","year":"2011","unstructured":"Sung L, Phillips R, Lehrnbecher T (2011) Time for paediatric febrile neutropenia guidelines\u2014children are not little adults. Eur J Cancer 47:811\u2013813","journal-title":"Eur J Cancer"},{"key":"1333_CR37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/pbc.22100","volume":"53","author":"V Uygun","year":"2009","unstructured":"Uygun V, Karasu GT, Ogunc D, Yesilipek A, Hazar V (2009) Piperacillin\/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study. Pediatr Blood Cancer 53:610\u2013614","journal-title":"Pediatr Blood Cancer"},{"key":"1333_CR38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E Elm von","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344\u2013349","journal-title":"J Clin Epidemiol"},{"key":"1333_CR39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1442-200X.2009.02952.x","volume":"52","author":"S Vural","year":"2010","unstructured":"Vural S, Erdem E, Gulec SG, Yildirmak Y, Kebudi R (2010) Imipenem\u2013cilastatin versus piperacillin\u2013tazobactam as monotherapy in febrile neutropenia. Pediatr Int 52:262\u2013267","journal-title":"Pediatr Int"},{"key":"1333_CR40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/08880010802016847","volume":"25","author":"I Yildirim","year":"2008","unstructured":"Yildirim I, Aytac S, Ceyhan M et al (2008) Piperacillin\/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. Pediatr Hematol Oncol 25:291\u2013299","journal-title":"Pediatr Hematol Oncol"},{"key":"1333_CR41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/1120009X.1991.11739100","volume":"3","author":"B Zulfikar","year":"1991","unstructured":"Zulfikar B, Devecioglu O, Anak S, Ovali F, Gedikoglu G (1991) The efficacy of mezlocillin\u2013amikacin combination in febrile neutropenic children with oncologic disease. J Chemother 3:250\u2013254","journal-title":"J Chemother"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-011-1333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-011-1333-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-011-1333-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T08:25:15Z","timestamp":1561019115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-011-1333-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,6]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1007\/s00520-011-1333-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,6]]}}}